| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.400 | None | 0.982 | 5 | 0 | 1994 | 2020 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
phenotype | 0.100 | None | 0.986 | 5 | 0 | 2002 | 2020 | ||||||||
|
ras homolog family member C | 0.641 | 0.308 | 0.77 |
|
phenotype | 0.400 | None | 1.000 | 5 | 0 | 2003 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.100 | None | 0.986 | 5 | 0 | 1994 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 5 | 0 | 1992 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.400 | None | 0.976 | 4 | 0 | 1997 | 2020 | ||||||||
|
integrin subunit beta 4 | 0.525 | 0.731 | 9.5E-19 |
|
phenotype | 0.100 | None | 1.000 | 4 | 0 | 2002 | 2020 | ||||||||
|
matrix metallopeptidase 14 | 0.447 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 4 | 0 | 1996 | 2020 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 4 | 0 | 2004 | 2020 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
phenotype | 0.400 | None | 0.989 | 4 | 0 | 1996 | 2020 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
phenotype | 0.400 | None | 0.979 | 4 | 0 | 1990 | 2020 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 0.986 | 4 | 0 | 1993 | 2019 | ||||||||
|
TIAM Rac1 associated GEF 1 | 0.579 | 0.731 | 0.96 |
|
phenotype | 0.100 | None | 0.938 | 4 | 0 | 2003 | 2019 | ||||||||
|
plasminogen activator, urokinase receptor | 0.536 | 0.731 | 5.3E-03 |
|
phenotype | 0.400 | None | 1.000 | 4 | 0 | 1998 | 2017 | ||||||||
|
fms related receptor tyrosine kinase 4 | 0.457 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.970 | 4 | 0 | 2000 | 2019 | ||||||||
|
BRMS1 transcriptional repressor and anoikis regulator | 0.597 | 0.615 | 1.6E-07 |
|
phenotype | 0.400 | None | 1.000 | 4 | 0 | 2000 | 2019 | ||||||||
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
phenotype | 0.100 | None | 0.944 | 4 | 0 | 2004 | 2019 | ||||||||
|
twist family bHLH transcription factor 1 | 0.397 | 0.846 | 0.34 |
|
phenotype | 0.400 | None | 0.980 | 4 | 0 | 2004 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
phenotype | 0.100 | None | 0.957 | 4 | 0 | 2000 | 2019 | ||||||||
|
fibroblast activation protein alpha | 0.496 | 0.808 | 1.9E-28 |
|
phenotype | 0.080 | None | 1.000 | 3 | 0 | 2003 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
phenotype | 0.400 | None | 0.969 | 3 | 0 | 1998 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
phenotype | 0.100 | None | 0.959 | 3 | 0 | 1996 | 2019 | ||||||||
|
TIMP metallopeptidase inhibitor 2 | 0.425 | 0.846 | 0.79 |
|
phenotype | 0.100 | None | 0.953 | 3 | 0 | 1993 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.932 | 3 | 0 | 2003 | 2020 | ||||||||
|
spleen associated tyrosine kinase | 0.475 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 0 | 2003 | 2019 |